Breaking
Longevity Research

Hospitals ramp up AI spending on clinical tools and patient

By Elise Dubois 2 min read
Hospitals ramp up AI spending on clinical tools and patient - ai spending hospitals
U.S. healthcare AI spending reached $3.7 billion in 2024, nearly doubling the previous year’s total.

Healthcare spending on artificial intelligence has surged past $3.7 billion in 2024, with providers accelerating investment beyond basic transcription tools into more sophisticated applications. This growth, nearly double the previous year’s total, represents the fastest adoption rate in the sector, according to a new analysis of U.S. healthcare executive spending trends.

Two application categories now command priority: clinical copilots, which assist with direct patient care, and front-office AI, focused on patient engagement. Spending in these areas climbed fivefold, reaching $550 million for clinical tools and $450 million for front-office systems, while traditional applications like ambient scribing and coding/billing saw slower growth. The shift signals a deliberate move away from purely administrative automation toward solutions that enhance clinical decision-making and workflow efficiency.

Established health IT companies maintain dominance in certain segments, particularly ambient scribing, where they secured 68% of new spending in 2026. However, providers are increasingly exploring niche AI vendors for specialized capabilities. OpenEvidence leads the clinical copilot market, though recent regulatory developments, including Utah’s sandbox approval for Doctronic to process prescription renewals, could expand opportunities for other decision-support platforms. Separately, ARPA-H has allocated $62.7 million to develop AI-driven agents for continuous heart failure monitoring, with plans to pursue FDA clearance.

Startups are also broadening their service scopes. Abridge, for instance, recently expanded its platform through a partnership with Availity to include real-time prior authorization tools, while Heidi integrated payer policy data via a collaboration with R1. These expansions reflect a provider preference for modular, adaptable AI solutions, even as legacy vendors retain control over core infrastructure tasks.

Ambient scribing remains a key area where traditional vendors hold sway. Legacy companies now control 46% of the market share in this domain, while startups have seen their share decline by 13% over the same period. The gap shows how providers weigh innovation against the need for seamless integration with existing electronic health records, particularly in high-stakes clinical environments.

Regulatory clarity and interoperability challenges continue to shape adoption patterns. Providers must handle these evolving frameworks while balancing immediate operational needs against long-term scalability.

Elise Dubois

Leave a Reply

Your email address will not be published. Required fields are marked *